A Single-center, Randomized, Blinded, and Positive Controlled Phase ??? Clinical Trial of the Safety and Preliminary Immunogenicity of Quadrivalent Influenza Vaccine (split Virion) in People Aged 3 Years and Above
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs Influenza virus split vaccine Chongqing Zhifei Biological Products (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 04 Feb 2025 New trial record